101 related articles for article (PubMed ID: 34060285)
1. Prognostic and clinicopathological implications of expression of Beclin-1 and hypoxia-inducible factor 1α in serous ovarian carcinoma: an immunohistochemical study.
Alabiad M; Harb O; Mandour D; Hemeda R; Z Ahmed R; El-Taher A; Osman G; Shalaby A; A A Alnemr A; T Abdelfattah M
Pol J Pathol; 2021; 72(1):23-38. PubMed ID: 34060285
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy.
El-Guindy DM; Ibrahim FM; Ali DA; El-Horany HE; Sabry NM; Elkholy RA; Mansour W; Helal DS
Virchows Arch; 2023 May; 482(5):823-837. PubMed ID: 36939902
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma.
Yano M; Miyazawa M; Ogane N; Ogasawara A; Hasegawa K; Narahara H; Yasuda M
Anticancer Res; 2021 Mar; 41(3):1647-1654. PubMed ID: 33788761
[TBL] [Abstract][Full Text] [Related]
5. Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma.
Osman NA; Abd El-Rehim DM; Kamal IM
Tumour Biol; 2015 Jun; 36(6):4293-9. PubMed ID: 25596085
[TBL] [Abstract][Full Text] [Related]
6. Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients.
Radwan SM; Hamdy NM; Hegab HM; El-Mesallamy HO
Cancer Biomark; 2016 Mar; 16(4):619-26. PubMed ID: 27002764
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.
Tang Z; Ow GS; Thiery JP; Ivshina AV; Kuznetsov VA
Int J Cancer; 2014 Jan; 134(2):306-18. PubMed ID: 23825028
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
[TBL] [Abstract][Full Text] [Related]
9. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical study.
Daponte A; Ioannou M; Mylonis I; Simos G; Minas M; Messinis IE; Koukoulis G
BMC Cancer; 2008 Nov; 8():335. PubMed ID: 19014607
[TBL] [Abstract][Full Text] [Related]
11. Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma.
Wu XY; Chen J; Cao QH; Dong M; Lin Q; Fan XJ; Xia Q; Chen ZH; Liu Q; Wan XB
Tumour Biol; 2013 Apr; 34(2):713-22. PubMed ID: 23225331
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
Abouhashem NS; Ibrahim DA; Mohamed AM
Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
[TBL] [Abstract][Full Text] [Related]
13. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
[TBL] [Abstract][Full Text] [Related]
14. Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma.
Suzuki H; Yano M; Miyazawa M; Miyazawa M; Ogane N; Hasegawa K; Tsuda H; Yoshida M; Okagaki R; Ishihara O; Yasuda M
J Ovarian Res; 2019 Jan; 12(1):7. PubMed ID: 30678691
[TBL] [Abstract][Full Text] [Related]
15. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy.
Abdelrahman AE; Fathy A; Elsebai EA; Nawar N; Etman WM
Ann Diagn Pathol; 2018 Aug; 35():27-37. PubMed ID: 30072015
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
Shen W; Li HL; Liu L; Cheng JX
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
[TBL] [Abstract][Full Text] [Related]
19. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma.
Wan XB; Fan XJ; Chen MY; Xiang J; Huang PY; Guo L; Wu XY; Xu J; Long ZJ; Zhao Y; Zhou WH; Mai HQ; Liu Q; Hong MH
Autophagy; 2010 Apr; 6(3):395-404. PubMed ID: 20150769
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
Kronblad A; Jirström K; Rydén L; Nordenskjöld B; Landberg G
Int J Cancer; 2006 May; 118(10):2609-16. PubMed ID: 16381002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
